Dr. Qbioma Martin

Dr. Obioma Martin Co-Authors Anticipated Inspirational Book, ‘Against All Odds’ with SuccessBooks and Esteemed Lisa Nichols

BALA CYNWYD, PA — Dr. Obioma Martin, a renowned figure in Early Childhood Education, Entrepreneurship, and Leadership, is set to co-author the forthcoming book “Against All Odds” with publishing house …

Dr. Obioma Martin Co-Authors Anticipated Inspirational Book, ‘Against All Odds’ with SuccessBooks and Esteemed Lisa Nichols Read More
Senator Judy Schwank


Larimar Therapeutics

Larimar Therapeutics Advances Nomlabofusp Clinical Program with First Patient Dosed in Open Label Extension Study

BALA CYNWYD, PA — Clinical-stage biotechnology company Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced the dosing of the first patient in an open label extension (OLE) study for its novel …

Larimar Therapeutics Advances Nomlabofusp Clinical Program with First Patient Dosed in Open Label Extension Study Read More

Centrak

CenTrak Unveils Industry’s First Scalable Bluetooth Low Energy Multi-Mode Platform for Healthcare

NEWTOWN, PA — CenTrak, a leader in the healthcare technology sector, has announced its latest breakthrough: the industry’s first scalable Bluetooth Low Energy (BLE) Multi-Mode Platform. This pioneering Real-Time Location …

CenTrak Unveils Industry’s First Scalable Bluetooth Low Energy Multi-Mode Platform for Healthcare Read More
Aprea Therapeutics

FDA Greenlights Aprea Therapeutics’ Investigational New Drug Application for Novel Cancer Treatment

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a clinical-stage biopharmaceutical company, has announced that its Investigational New Drug (IND) application for APR-1051 has been cleared by the U.S. Food …

FDA Greenlights Aprea Therapeutics’ Investigational New Drug Application for Novel Cancer Treatment Read More